TABLE 2.

Relative sensitivity and specificity of Anyplex compared to those of hc2 and cobas in women ≥30 years old and in the total study population^a

Comparison by group and clinical outcome	Relative sensitivity	Relative specificity	pMcN	pNi
Anyplex vs hc2
Women ≥30 old
CIN2+	1.01 (0.96–1.06)		0.655	0.001
CIN3+	1.02 (0.96–1.07)		0.564	0.003
≤CIN1		1.01 (1.00–1.03)	0.013	0.000
Total study population
CIN2+	1.01 (0.97–1.04)		0.655	<0.001
CIN3+	1.01 (0.97–1.06)		0.564	0.001
≤CIN1		1.02 (1.00–1.03)	0.008	<0.001
Anyplex vs cobas
Women ≥30 old
CIN2+	1.00 (0.97–1.03)		1.000	0.002
CIN3+	1.02 (0.99–1.05)		0.317	0.003
≤CIN1		1.00 (0.99–1.01)	0.827	0.002
Total study population
CIN2+	1.01 (0.98–1.04)		0.564	<0.001
CIN3+	1.01 (0.99–1.04)		0.317	0.001
≤CIN1		1.00 (0.99–1.01)	0.858	<0.001

^ap_McN, P value for McNemar test; p_Ni, P value in noninferiority testing.